Science has its own dynamics. We nurture agility while keeping a close eye on the ultimate goal of generating financial and societal return. We help to start, build and accelerate ventures with tranched investments, balancing risk and return.

Thuja was a founding investor in Argenx, now a NASDAQ listed company, when it was only an idea of three entrepreneurs, incubated it at the Utrecht Science Park and ultimately supported it actively through its Euronext IPO and beyond.

Case example:

Argenx was founded based on an initial investment by Thuja. Tim Vanhauwermeiren and Hans de Haard approached Thuja with a convincing idea and a plan, that Thuja supported throughout its growth.

Argenx was founded based on an initial investment by Thuja. Tim Vanhauwermeiren and Hans de Haard approached Thuja with a convincing idea and a plan, that Thuja supported throughout its growth.

Okapi Sciences developed antiviral drugs for livestock as well as pets. Thuja supported Okapi during different scaling phases until its acquisition by Aratana in 2014.

Okapi Sciences developed antiviral drugs for livestock as well as pets. Thuja supported Okapi during different scaling phases until its acquisition by Aratana in 2014.